KOSPI (SEOUL.NDX)

Close: 3 140.31 (-68.68), Jan 26, 2021
Positive

Automatic technical analysis. Medium term, Jan 26, 2021

Investors have paid higher prices over time to buy KOSPI and the index is in a rising trend channel in the medium long term. Rising trends indicate that the market experiences positive development and that buy interest among investors is increasing. There is no resistance in the price chart and further rise is indicated. In case of a negative reaction, the index has support at approximately 2430 points. Volume has previously been high at price tops and low at price bottoms. This strengthens the trend. RSI is above 70 after a good price increase the past weeks. The index has strong positive momentum and further increase is indicated. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. The index is overall assessed as technically positive for the medium long term.

Recommendation one to six months: Positive

Period  
Vol.bal. Volatility Liquidity +/- %
1 day-1.04%0.86-2.14%
5 days46.433.66%1.10+1.54%
22 days-7.4810.93%1.26+14.87%
66 days18.7524.57%1.15+32.45%

More analyses of KOSPI

chart KOSPI (SEOUL) Candlesticks 22 Days
Candlesticks
chart KOSPI (SEOUL) Short term
Short term: Hold
chart KOSPI (SEOUL) Medium term
Medium term: Positive
chart KOSPI (SEOUL) Long term
Long term: Positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now